World Research Reports’ Post

𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027 Download PDF Brochure @ https://lnkd.in/d7K4Bc5G The global 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $10.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2022, 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 13.0%.  Many government bodies and private organizations across the globe are investing in the field of #bioinformatics. These investments leads to technological advancements in bioinformatics services, which, in turn, have improved the quality of these services. For instance, in 2016, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 (𝐄𝐌𝐁𝐋), an intergovernmental organization and pioneer in bioinformatics research, received funds from the 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, 𝐁𝐫𝐢𝐭𝐢𝐬𝐡 𝐇𝐞𝐚𝐫𝐭 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧, #CancerResearchUK, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐂𝐨𝐦𝐦𝐢𝐬𝐬𝐢𝐨𝐧, 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program (HFSP), 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐞 𝐔𝐊, 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐏𝐨𝐥𝐢𝐜𝐲 𝐆𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧, 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, 𝐭𝐡𝐞 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡, 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧, 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐔𝐊, 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥𝐬 𝐔𝐊, 𝐚𝐧𝐝 𝐖𝐞𝐥𝐥𝐜𝐨𝐦𝐞, 𝐟𝐨𝐫 𝐑&𝐃 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐢𝐞𝐥𝐝 𝐨𝐟 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Syntekabio Inc..      BioSpyder Technologies      Genealogy      1928 Diagnostics      Metabolomic Diagnostics      Xbiome      Bencos Research Solutions Pvt. Ltd..      NaturalAntibody Genomics Core Leuven     Polo GGB - Polo d'Innovazione di Genomica, Genetica e Biologia      BMR Genomics S.r.l. Diagnostech (Pty) Ltd Traitology Workflow Informatics Corp.     GeneGoCell Inc.   Sciencewerke Pte Ltd 3billion Eminent Biosciences    Fulcrum Genomics LLC      Theiagen Genomics Institute for Genetic Engineering and Biotechnology, INGEB      Intus Bio KYTOS Gene2info GeNext Genomics Pvt Ltd Arrayjet Via Scientific, Inc..      Kinomica MRD LifeSciences Pvt Ltd BioAxis DNA Research Centre (P) Ltd OmicScouts IMol      Isomerase      National Institute for Genomics and Advanced Biotechnology (NIGAB)     ADNTRO GENETICS    Gene Codes Corporation      Centre for Microbiome Research

Do you know of these bioinformatics companies making waves in the biopharma industry? 🌊 Bioinformatics is a field of science that integrates computer technology to analyze biological data to boost healthcare research. 🖥️ The bioinformatics industry has a market value of $16.3 billion at present, and is forecasted to reach nearly $24 billion in five years. 📈 Most biotechs rely on bioinformatics in drug discovery to improve their chances of viable candidates making it to the clinic. 🏥 Check out our latest article on five bioinformatics companies making a difference in the biopharma industry in 2024! 👇 https://lnkd.in/deQ7pvJY #bioinformatics #biopharma #healthcareresearch #drugdiscovery #biotechinnovation #BiotechIndustry #healthcaretech #scientificadvances Synthace | Verge Genomics | VeriSIM Life | Recursion | Twist Bioscience | Illumina | QIAGEN | Thermo Fisher Scientific

𝐓𝐡𝐞 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 10.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2022 𝐚𝐧𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐚𝐭 𝐚 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 13.0% 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dN62vKZ9 The use of computer technology to comprehend and utilise biological and biomedical data effectively is known as bioinformatics. It is the field responsible for storing, analysing, and interpreting the Big Data gathered during clinical settings or as a result of life science investigations. The growth of the bioinformatics market is driven by the increasing public and private-sector funding for bioinformatics, growing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure, and decreasing cost of genome sequencing. However, the high cost of equipment is hindering the growth of this market. #NorthAmerica dominated the bioinformatics market in 2021 and is expected to grow at an 12.7% CAGR during the forecast period. The North America holds large share in the global bioinformatics market owing to factors such as government support for genomic research, presence of top key players in the region, reduced cost of sequencing, increased awareness of bioinformatics services, and increased number of genomic research activities (and the corresponding adoption of bioinformatics) in the region are driving the growth of the bioinformatics market in North America. Thermo Fisher Scientific, Eurofins Scientific Finland Oy, QIAGEN, Agilent Technologies, Illumina, Waters Corporation, DNASTAR, NeoGenomics Laboratories, PerkinElmer, GENEWIZ, UK, BGI Group, SOPHiA GENETICS, Source BioScience

𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐞, 𝐀𝐧𝐚𝐥𝐲𝐳𝐞, 𝐄𝐯𝐨𝐥𝐯𝐞: 📈 𝐓𝐡𝐞 𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐁𝐨𝐨𝐦! The global bioinformatics market size was valued at USD 10.1 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 13.7% from 2023 to 2030. 𝐅𝐨𝐫 𝐌𝐨𝐫𝐞: https://lnkd.in/gHXcB-tB According to an article published by Stanford Medicine in January 2022, research conducted by Stanford scientists showed that a DNA sequencing technique could sequence a human genome in about 8 hours. Such developments can boost demand for genomics and, consequently, the bioinformatics sector. Bioinformatics data storage and analysis applications are capable of storing a large amount of genomic and proteomic information to facilitate research activities in fields ranging from aging and carcinogenesis to preventive therapy for genetic diseases. This factor is also expected to significantly contribute to the growth of this industry over the forecast period. The COVID-19 pandemic has significantly impacted the bioinformatics market. Researchers and physicians resorted to bioinformatics to help them comprehend the virus and create diagnostic tests and cures. As a result, the demand for bioinformatics tools and services showed a noticeable surge during this period. Researchers may quickly analyze and interpret vast amounts of chemical and biological data by integrating bioinformatics with cheminformatics and drug designing, which results in more focused and successful drug development efforts. For instance, in June 2021, the U.S. Food and Drug Administration and the Center for Drug Evaluation and Research (CDER) sanctioned 26 new molecular entities (NMEs), which will drive the growth of research and development activities. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞: https://lnkd.in/gvSDR-F9 The area of proteomics has also experienced extensive R&D investments in recent years, and bioinformatics is integral in analyzing and managing the resultant data. Also, this makes it simpler to handle heterogeneous and large data sets, introduce new algorithms, and improve the knowledge discovery procedure. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: European Bioinformatics Institute | EMBL-EBI | Data analyses and Bioinformatics | QIAGEN | Planet Pharma | Zifo | Natera | MEDGENOME | Novogene America | SRI | The Jackson Laboratory | Excelra | NMDP | Be The Match | Axle | Dotmatics | Vasta Global | Instem | GenScript #Bioinformatics #Genomics #DataScience #ComputationalBiology #BigData #PrecisionMedicine #HealthcareInnovation #GeneticResearch #Biotechnology #Omics #MachineLearning #AIinHealthcare #DataAnalytics #BioinformaticsTools #LifeSciences

𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027 Download PDF Brochure @ https://lnkd.in/d7K4Bc5G The global 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $10.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2022, 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 13.0%. Many government bodies and private organizations across the globe are investing in the field of #bioinformatics. These investments leads to technological advancements in bioinformatics services, which, in turn, have improved the quality of these services. For instance, in 2016, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 (𝐄𝐌𝐁𝐋), an intergovernmental organization and pioneer in bioinformatics research, received funds from the 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, 𝐁𝐫𝐢𝐭𝐢𝐬𝐡 𝐇𝐞𝐚𝐫𝐭 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧, #CancerResearchUK, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐂𝐨𝐦𝐦𝐢𝐬𝐬𝐢𝐨𝐧, 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program (HFSP), 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐞 𝐔𝐊, 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐏𝐨𝐥𝐢𝐜𝐲 𝐆𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧, 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, 𝐭𝐡𝐞 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡, 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧, 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐔𝐊, 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥𝐬 𝐔𝐊, 𝐚𝐧𝐝 𝐖𝐞𝐥𝐥𝐜𝐨𝐦𝐞, 𝐟𝐨𝐫 𝐑&𝐃 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐢𝐞𝐥𝐝 𝐨𝐟 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: BioTuring      Neon Therapeutics      CareDx, Inc.      Inflammatix, Inc.    Seven Bridges      Laguna Source      Celmatix    NMDP BioTherapies    Aitia      Be The Match BioTherapies     GigaGen Inc    Genesis Biotechnology Group      Phase Genomics      Portal Innovations, LLC      Sequencing  GENOSKIN   Genuity Science Decipher by Veracyte      Genome International ROSALIND      ChromaCode, Inc..      Abiosciences      Parabon      Active Motif      Admera Health      Strand Life Sciences      Bridge Informatics      SOPHiA GENETICS      Achilles Therapeutics plc    Lifebit      Genomics England      Health in Code Group      OpGen, Inc.     BDG LifeSciences     Centre for Genomic Regulation (CRG)      CellCarta     Clevergene 

🧬✨ Bioinformatics Workflow of Next-Generation Sequencing (NGS) ✨🧬 #BioinfoTuesdays #NGS NGS technologies, such as #Illumina and #IonTorrent, have unlocked the possibility of deeper #genome exploration by simultaneously analysing millions of genomic regions in multiple samples. However, to derive valuable insights from the raw data output, proper processing and subsequent analysis are required. Do you know the standard steps to process NGS raw data? Let's dive in! 🧬 🔍 Base Calling: The raw signal generated during sequencing is converted to nucleotide sequences by the instrument and stored in a #FastQ file, alongside their corresponding quality scores. ✂️ Quality Control: This step is crucial to ensure #high-quality data. Sequence quality, read length, and base composition, among other factors, are assessed. Adaptors added during library preparation are removed, and if necessary, low-quality sequences are trimmed, generating a trimmed FastQ file. 🎯 Reads Alignment: The filtered reads (nucleotide sequences) are #aligned to a reference genome/transcriptome to identify the likely origin of the observed sequences. This information is recorded in a Sequence Alignment Map (SAM) file, which can be converted into a Binary Alignment Map (BAM) file to save space. 🔍 Variant Calling: By comparing aligned reads to the reference sequence, genetic variations such as single nucleotide polymorphisms (#SNPs) and insertions/deletions (#InDels) can be identified. The Variant Call Format (VCF) is commonly used to store these variant calls. 📝 Annotation: It's time to gather more #information about the identified variants, such as corresponding #genes, functional impact predictions, and allele #frequencies. Annotation data is often stored in tabular formats like Comma-Separated Values (CSV), Microsoft Excel (XLSX), or Tab-Separated Values (TSV), facilitating easy integration with other tools and databases. 📈 Downstream Analysis: Finally, we interpret the variant data, unveiling biological #insights. This includes statistical analyses, pathway enrichment studies, and genotype-phenotype #associations. Results are typically recorded in tabular formats for further interpretation and visualisation. Are you interested in learning more about bioinformatics? Share your thoughts and experiences in the comments below! And don't forget to follow me for more insights into bioinformatics and genomics. 💻🔍 #bioinformatics #genetics #genomics #biology #biotechnology #lifesciences #dna #sequencing #ngs #alignment #sciencecommunication #bioinformatica #genetica #genomica #biologia #biotecnologia

𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027 Download PDF Brochure @ https://lnkd.in/d7K4Bc5G The global 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $10.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2022, 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 13.0%. Many government bodies and private organizations across the globe are investing in the field of #bioinformatics. These investments leads to technological advancements in bioinformatics services, which, in turn, have improved the quality of these services. For instance, in 2016, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 (𝐄𝐌𝐁𝐋), an intergovernmental organization and pioneer in bioinformatics research, received funds from the 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, 𝐁𝐫𝐢𝐭𝐢𝐬𝐡 𝐇𝐞𝐚𝐫𝐭 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧, #CancerResearchUK, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐂𝐨𝐦𝐦𝐢𝐬𝐬𝐢𝐨𝐧, 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program (HFSP), 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐞 𝐔𝐊, 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐏𝐨𝐥𝐢𝐜𝐲 𝐆𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧, 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, 𝐭𝐡𝐞 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡, 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧, 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐔𝐊, 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥𝐬 𝐔𝐊, 𝐚𝐧𝐝 𝐖𝐞𝐥𝐥𝐜𝐨𝐦𝐞, 𝐟𝐨𝐫 𝐑&𝐃 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐢𝐞𝐥𝐝 𝐨𝐟 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: EIRNA Bio      Loschmidt Laboratories, Faculty of Science, Masaryk University      MicrobesNG     Genome Prairie  Sentieon GenomeFan      Genetics Generation Advancement Corp.     DNA GTx LAB    PetaGene  PIRCHE iLife Discoveries P L Nag Research Labs      Chan Soon-Shiong Institute of Molecular Medicine at Windber    Targos Molecular Pathology GmbH      NeoSensing   EDGC(EONE-DIAGNOMICS Genome Center))      Theragen Bio    Inqaba Biotec West Africa MOgene      BioSol Centre  metanomics GmbH      Genetrics     Wobble Genomics  Xome Life Sciences    BioMed Technology Holdings Limited      Computational Biology Research Center of Amirkabir university (CBRC)     Infinity Bio, Inc.     Shanghai Biotechnology Corporation (SBC) Filgen, Inc.    Conceptual MindWorks, Inc  Gescher's Lab of Technical Microbiology - TUHH    Kinexus      ABEx Bio-Research Center    Isomab Ltd    DoD Biotechnology HPC Software Applications Institute   RefinedScience Experiome

𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027 Download PDF Brochure @ https://lnkd.in/d7K4Bc5G The global 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭, 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $10.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2022, 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $18.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 13.0%.  Many government bodies and private organizations across the globe are investing in the field of #bioinformatics. These investments leads to technological advancements in bioinformatics services, which, in turn, have improved the quality of these services. For instance, in 2016, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 (𝐄𝐌𝐁𝐋), an intergovernmental organization and pioneer in bioinformatics research, received funds from the 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, 𝐁𝐫𝐢𝐭𝐢𝐬𝐡 𝐇𝐞𝐚𝐫𝐭 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧, #CancerResearchUK, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐂𝐨𝐦𝐦𝐢𝐬𝐬𝐢𝐨𝐧, 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧, the 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program (HFSP), 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐞 𝐔𝐊, 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐏𝐨𝐥𝐢𝐜𝐲 𝐆𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞 𝐎𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧, 𝐭𝐡𝐞 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥, 𝐭𝐡𝐞 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬 𝐨𝐟 𝐇𝐞𝐚𝐥𝐭𝐡, 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧, 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐔𝐊, 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐂𝐨𝐮𝐧𝐜𝐢𝐥𝐬 𝐔𝐊, 𝐚𝐧𝐝 𝐖𝐞𝐥𝐥𝐜𝐨𝐦𝐞, 𝐟𝐨𝐫 𝐑&𝐃 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐢𝐞𝐥𝐝 𝐨𝐟 𝐛𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬. 𝐄𝐧𝐭𝐞𝐫𝐩𝐫𝐢𝐬𝐞𝐬 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐰𝐢𝐭𝐡𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Laboratory of Human Genetic Diversity (LDGH))      ALACRiS Theranostics GmbH      agrematch      Istituto di Tecnologie Biomediche, CNR    ScienceVision Sdn Bhd     SynBioUK    EdiGene Inc.   SZAOMICS   AMPEL BioSolutions      Ferris Genomics Inc      CJ Bioscience African Biosciences Ltd      Intelliseq    NEBION      Weatherden  Cell X Technologies   Secarna Pharmaceuticals      EEAD-CSIC    actome      PEPTINOV     FHAIVE     XDx is now CareDx, Inc.      Genomix4Life srl MrBiologist     Singlera Genomics Incorporated Edinburgh Genomics Sirona Dx   geneXplain      CeBiTec - Center for Biotechnology (Bielefeld University)    Monoceros Biosystems GenieBiome Limited 精進微生物科技有限公司 IGA Technology Services      Insilico Medicine Taiwan (英科智能) Phalanx Biotech Group Fusion Genomics Corporation   Pascific Double-Helix